Trial Outcomes & Findings for Brief Behavioral Intervention for Dyspnea in Patients With Advanced Lung Cancer (NCT NCT03089125)
NCT ID: NCT03089125
Last Updated: 2025-02-27
Results Overview
Compare the difference between study groups in the Modified Medical Research Council Dyspnea Scale severity score at 8 weeks. The Modified Medical Research Council Dyspnea Scale scores range from 0 (minimum) to 4 (maximum), with higher scores indicating more severe dyspnea.
COMPLETED
NA
247 participants
8 weeks
2025-02-27
Participant Flow
Participant milestones
| Measure |
Usual Care
Patients will receive any usual care for their dyspnea as deemed appropriate by their clinicians.
Usual Care: Patients will receive any usual care for their dyspnea as deemed appropriate by their clinicians
|
Dyspnea Intervention
Dyspnea intervention will be administered over two sessions
Patients will receive:
* Psychoeducation
* Relaxation training for reducing physiological stress
* Behavioral techniques for managing acute breathlessness
Dyspnea Intervention: Dyspnea intervention will be administered over two sessions
Patients will receive:
* Psychoeducation
* Relaxation training for reducing physiological stress
* Behavioral techniques for managing acute breathlessness
Usual Care: Patients will receive any usual care for their dyspnea as deemed appropriate by their clinicians
|
|---|---|---|
|
Overall Study
STARTED
|
121
|
126
|
|
Overall Study
COMPLETED
|
99
|
94
|
|
Overall Study
NOT COMPLETED
|
22
|
32
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
6 participants in the Usual Care Group and 9 participants in the Dyspnea Intervention Group did not complete the baseline Godin-Shephard Leisure Time Physical Activity Questionnaire.
Baseline characteristics by cohort
| Measure |
Usual Care
n=121 Participants
Patients will receive any usual care for their dyspnea as deemed appropriate by their clinicians.
Usual Care: Patients will receive any usual care for their dyspnea as deemed appropriate by their clinicians
|
Dyspnea Intervention
n=126 Participants
Dyspnea intervention will be administered over two sessions
Patients will receive:
* Psychoeducation
* Relaxation training for reducing physiological stress
* Behavioral techniques for managing acute breathlessness
Dyspnea Intervention: Dyspnea intervention will be administered over two sessions
Patients will receive:
* Psychoeducation
* Relaxation training for reducing physiological stress
* Behavioral techniques for managing acute breathlessness
Usual Care: Patients will receive any usual care for their dyspnea as deemed appropriate by their clinicians
|
Total
n=247 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Continuous
|
65.44 years
STANDARD_DEVIATION 10.08 • n=121 Participants
|
66.83 years
STANDARD_DEVIATION 11.47 • n=126 Participants
|
66.15 years
STANDARD_DEVIATION 10.81 • n=247 Participants
|
|
Sex: Female, Male
Female
|
70 Participants
n=121 Participants
|
68 Participants
n=126 Participants
|
138 Participants
n=247 Participants
|
|
Sex: Female, Male
Male
|
51 Participants
n=121 Participants
|
58 Participants
n=126 Participants
|
109 Participants
n=247 Participants
|
|
Ethnicity (NIH/OMB)
Hispanic or Latino
|
1 Participants
n=121 Participants
|
3 Participants
n=126 Participants
|
4 Participants
n=247 Participants
|
|
Ethnicity (NIH/OMB)
Not Hispanic or Latino
|
118 Participants
n=121 Participants
|
117 Participants
n=126 Participants
|
235 Participants
n=247 Participants
|
|
Ethnicity (NIH/OMB)
Unknown or Not Reported
|
2 Participants
n=121 Participants
|
6 Participants
n=126 Participants
|
8 Participants
n=247 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=121 Participants
|
0 Participants
n=126 Participants
|
0 Participants
n=247 Participants
|
|
Race (NIH/OMB)
Asian
|
2 Participants
n=121 Participants
|
6 Participants
n=126 Participants
|
8 Participants
n=247 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=121 Participants
|
0 Participants
n=126 Participants
|
0 Participants
n=247 Participants
|
|
Race (NIH/OMB)
Black or African American
|
2 Participants
n=121 Participants
|
5 Participants
n=126 Participants
|
7 Participants
n=247 Participants
|
|
Race (NIH/OMB)
White
|
113 Participants
n=121 Participants
|
110 Participants
n=126 Participants
|
223 Participants
n=247 Participants
|
|
Race (NIH/OMB)
More than one race
|
2 Participants
n=121 Participants
|
4 Participants
n=126 Participants
|
6 Participants
n=247 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
2 Participants
n=121 Participants
|
1 Participants
n=126 Participants
|
3 Participants
n=247 Participants
|
|
Region of Enrollment
United States
|
121 participants
n=121 Participants
|
126 participants
n=126 Participants
|
247 participants
n=247 Participants
|
|
Modified Medical Research Council Dyspnea Scale (mMRCDS)
|
2.60 units on a scale
STANDARD_DEVIATION 0.75 • n=121 Participants
|
2.59 units on a scale
STANDARD_DEVIATION 0.72 • n=126 Participants
|
2.60 units on a scale
STANDARD_DEVIATION 0.73 • n=247 Participants
|
|
Cancer Dyspnoea Scale (CDS)
|
12.61 units on a scale
STANDARD_DEVIATION 7.51 • n=121 Participants
|
11.13 units on a scale
STANDARD_DEVIATION 6.51 • n=126 Participants
|
11.85 units on a scale
STANDARD_DEVIATION 7.05 • n=247 Participants
|
|
Functional Assessment of Cancer Therapy - Lung (FACT-L)
|
87.23 units on a scale
STANDARD_DEVIATION 16.36 • n=121 Participants
|
90.19 units on a scale
STANDARD_DEVIATION 18.59 • n=126 Participants
|
88.74 units on a scale
STANDARD_DEVIATION 17.56 • n=247 Participants
|
|
Hospital Anxiety and Depression Scale (HADS) - Anxiety Subscale
|
6.68 units on a scale
STANDARD_DEVIATION 3.76 • n=121 Participants
|
5.37 units on a scale
STANDARD_DEVIATION 3.80 • n=126 Participants
|
6.01 units on a scale
STANDARD_DEVIATION 3.83 • n=247 Participants
|
|
Hospital Anxiety and Depression Scale (HADS) - Depression Subscale
|
6.40 units on a scale
STANDARD_DEVIATION 3.16 • n=121 Participants
|
5.73 units on a scale
STANDARD_DEVIATION 3.72 • n=126 Participants
|
6.06 units on a scale
STANDARD_DEVIATION 3.47 • n=247 Participants
|
|
Godin-Shephard Leisure Time Physical Activity Questionnaire
|
11.19 units on a scale
STANDARD_DEVIATION 18.20 • n=115 Participants • 6 participants in the Usual Care Group and 9 participants in the Dyspnea Intervention Group did not complete the baseline Godin-Shephard Leisure Time Physical Activity Questionnaire.
|
12.29 units on a scale
STANDARD_DEVIATION 16.91 • n=117 Participants • 6 participants in the Usual Care Group and 9 participants in the Dyspnea Intervention Group did not complete the baseline Godin-Shephard Leisure Time Physical Activity Questionnaire.
|
11.75 units on a scale
STANDARD_DEVIATION 17.53 • n=232 Participants • 6 participants in the Usual Care Group and 9 participants in the Dyspnea Intervention Group did not complete the baseline Godin-Shephard Leisure Time Physical Activity Questionnaire.
|
|
Actigraphy
|
50.48 Percent time spent immobile while awake
STANDARD_DEVIATION 13.62 • n=84 Participants • 37 participants in the Usual Care Group and 37 participants in the Dyspnea Intervention Group did not have three consecutive days of actigraphy data at baseline.
|
47.61 Percent time spent immobile while awake
STANDARD_DEVIATION 11.19 • n=89 Participants • 37 participants in the Usual Care Group and 37 participants in the Dyspnea Intervention Group did not have three consecutive days of actigraphy data at baseline.
|
49.00 Percent time spent immobile while awake
STANDARD_DEVIATION 12.48 • n=173 Participants • 37 participants in the Usual Care Group and 37 participants in the Dyspnea Intervention Group did not have three consecutive days of actigraphy data at baseline.
|
PRIMARY outcome
Timeframe: 8 weeksPopulation: Reasons for missing data include participants being unable to complete study measures due to worsening illness or death, withdrawing from the study, declining to complete the measures, or being lost to follow-up or transferring care.
Compare the difference between study groups in the Modified Medical Research Council Dyspnea Scale severity score at 8 weeks. The Modified Medical Research Council Dyspnea Scale scores range from 0 (minimum) to 4 (maximum), with higher scores indicating more severe dyspnea.
Outcome measures
| Measure |
Usual Care
n=98 Participants
Patients will receive any usual care for their dyspnea as deemed appropriate by their clinicians.
Usual Care: Patients will receive any usual care for their dyspnea as deemed appropriate by their clinicians
|
Dyspnea Intervention
n=92 Participants
Dyspnea intervention will be administered over two sessions
Patients will receive:
* Psychoeducation
* Relaxation training for reducing physiological stress
* Behavioral techniques for managing acute breathlessness
Dyspnea Intervention: Dyspnea intervention will be administered over two sessions
Patients will receive:
* Psychoeducation
* Relaxation training for reducing physiological stress
* Behavioral techniques for managing acute breathlessness
Usual Care: Patients will receive any usual care for their dyspnea as deemed appropriate by their clinicians
|
|---|---|---|
|
Modified Medical Research Council Dyspnea Scale (mMRCDS)
|
1.88 units on a scale
Interval 1.69 to 2.07
|
1.55 units on a scale
Interval 1.35 to 1.75
|
PRIMARY outcome
Timeframe: 8 weeksPopulation: Reasons for missing data include participants being unable to complete study measures due to worsening illness or death, withdrawing from the study, declining to complete the measures, or being lost to follow-up or transferring care.
Compare the difference between study groups in the Cancer Dyspnoea Scale scores at 8 weeks. The Cancer Dyspnoea Scale scores range from 0 (minimum) to 48 (maximum), with higher scores indicating worse dyspnea.
Outcome measures
| Measure |
Usual Care
n=99 Participants
Patients will receive any usual care for their dyspnea as deemed appropriate by their clinicians.
Usual Care: Patients will receive any usual care for their dyspnea as deemed appropriate by their clinicians
|
Dyspnea Intervention
n=92 Participants
Dyspnea intervention will be administered over two sessions
Patients will receive:
* Psychoeducation
* Relaxation training for reducing physiological stress
* Behavioral techniques for managing acute breathlessness
Dyspnea Intervention: Dyspnea intervention will be administered over two sessions
Patients will receive:
* Psychoeducation
* Relaxation training for reducing physiological stress
* Behavioral techniques for managing acute breathlessness
Usual Care: Patients will receive any usual care for their dyspnea as deemed appropriate by their clinicians
|
|---|---|---|
|
Cancer Dyspnoea Scale (CDS)
|
10.01 units on a scale
Interval 8.87 to 11.15
|
9.47 units on a scale
Interval 8.28 to 10.65
|
SECONDARY outcome
Timeframe: 8 weeksPopulation: Reasons for missing data include participants being unable to complete study measures due to worsening illness or death, withdrawing from the study, declining to complete the measures, or being lost to follow-up or transferring their care to another institution.
Compare the difference between study groups in the Functional Assessment of Cancer Therapy - Lung Scale scores at 8 weeks. The Functional Assessment of Cancer Therapy - Lung Scale scores range from 0 (minimum) to 136 (maximum), with higher scores indicating better quality of life.
Outcome measures
| Measure |
Usual Care
n=97 Participants
Patients will receive any usual care for their dyspnea as deemed appropriate by their clinicians.
Usual Care: Patients will receive any usual care for their dyspnea as deemed appropriate by their clinicians
|
Dyspnea Intervention
n=91 Participants
Dyspnea intervention will be administered over two sessions
Patients will receive:
* Psychoeducation
* Relaxation training for reducing physiological stress
* Behavioral techniques for managing acute breathlessness
Dyspnea Intervention: Dyspnea intervention will be administered over two sessions
Patients will receive:
* Psychoeducation
* Relaxation training for reducing physiological stress
* Behavioral techniques for managing acute breathlessness
Usual Care: Patients will receive any usual care for their dyspnea as deemed appropriate by their clinicians
|
|---|---|---|
|
Functional Assessment of Cancer Therapy - Lung (FACT-L)
|
91.40 units on a scale
Interval 88.91 to 93.89
|
93.00 units on a scale
Interval 90.43 to 95.57
|
SECONDARY outcome
Timeframe: 8 weeksPopulation: Reasons for missing data include participants being unable to complete study measures due to worsening illness or death, withdrawing from the study, declining to complete the measures, or being lost to follow-up or transferring their care to another institution.
Compare the difference between study groups in the Hospital Anxiety and Depression Scale - Anxiety Subscale scores at 8 weeks. The Hospital Anxiety and Depression Scale - Anxiety Subscale scores range from 0 (minimum) to 21 (maximum), with higher scores indicating worse anxiety symptoms.
Outcome measures
| Measure |
Usual Care
n=99 Participants
Patients will receive any usual care for their dyspnea as deemed appropriate by their clinicians.
Usual Care: Patients will receive any usual care for their dyspnea as deemed appropriate by their clinicians
|
Dyspnea Intervention
n=92 Participants
Dyspnea intervention will be administered over two sessions
Patients will receive:
* Psychoeducation
* Relaxation training for reducing physiological stress
* Behavioral techniques for managing acute breathlessness
Dyspnea Intervention: Dyspnea intervention will be administered over two sessions
Patients will receive:
* Psychoeducation
* Relaxation training for reducing physiological stress
* Behavioral techniques for managing acute breathlessness
Usual Care: Patients will receive any usual care for their dyspnea as deemed appropriate by their clinicians
|
|---|---|---|
|
Hospital Anxiety and Depression Scale (HADS) - Anxiety Subscale
|
5.85 units on a scale
Interval 5.27 to 6.42
|
5.84 units on a scale
Interval 5.25 to 6.43
|
SECONDARY outcome
Timeframe: 8 weeksPopulation: Reasons for missing data include participants being unable to complete study measures due to worsening illness or death, withdrawing from the study, declining to complete the measures, or being lost to follow-up or transferring their care to another institution.
Compare the difference between study groups in the Hospital Anxiety and Depression Scale - Depression Subscale scores at 8 weeks. The Hospital Anxiety and Depression Scale - Depression Subscale scores range from 0 (minimum) to 21 (maximum), with higher scores indicating worse depression symptoms.
Outcome measures
| Measure |
Usual Care
n=99 Participants
Patients will receive any usual care for their dyspnea as deemed appropriate by their clinicians.
Usual Care: Patients will receive any usual care for their dyspnea as deemed appropriate by their clinicians
|
Dyspnea Intervention
n=92 Participants
Dyspnea intervention will be administered over two sessions
Patients will receive:
* Psychoeducation
* Relaxation training for reducing physiological stress
* Behavioral techniques for managing acute breathlessness
Dyspnea Intervention: Dyspnea intervention will be administered over two sessions
Patients will receive:
* Psychoeducation
* Relaxation training for reducing physiological stress
* Behavioral techniques for managing acute breathlessness
Usual Care: Patients will receive any usual care for their dyspnea as deemed appropriate by their clinicians
|
|---|---|---|
|
Hospital Anxiety and Depression Scale (HADS) - Depression Subscale
|
6.09 units on a scale
Interval 5.5 to 6.67
|
5.59 units on a scale
Interval 4.99 to 6.2
|
SECONDARY outcome
Timeframe: 8 weeksPopulation: Reasons for missing data include participants being unable to complete study measures due to worsening illness or death, withdrawing from the study, declining to complete the measures, or being lost to follow-up or transferring their care to another institution.
Compare the difference between study groups in the Godin-Shephard Leisure Time Physical Activity Questionnaire scores at 8 weeks. The Godin-Shephard Leisure Time Physical Activity Questionnaire is a 4-item measure that assesses the frequency and extent of physical activity during free time over the course of one week, with scores ranging from 0 (minimum; insufficiently active) to 24 or greater (maximum; active), with higher scores indicating greater physical activity.
Outcome measures
| Measure |
Usual Care
n=90 Participants
Patients will receive any usual care for their dyspnea as deemed appropriate by their clinicians.
Usual Care: Patients will receive any usual care for their dyspnea as deemed appropriate by their clinicians
|
Dyspnea Intervention
n=74 Participants
Dyspnea intervention will be administered over two sessions
Patients will receive:
* Psychoeducation
* Relaxation training for reducing physiological stress
* Behavioral techniques for managing acute breathlessness
Dyspnea Intervention: Dyspnea intervention will be administered over two sessions
Patients will receive:
* Psychoeducation
* Relaxation training for reducing physiological stress
* Behavioral techniques for managing acute breathlessness
Usual Care: Patients will receive any usual care for their dyspnea as deemed appropriate by their clinicians
|
|---|---|---|
|
Activity Level (Self-report: Godin-Shephard Leisure Time Physical Activity Questionnaire)
|
12.73 units on a scale
Interval 8.43 to 17.03
|
11.24 units on a scale
Interval 6.5 to 15.98
|
SECONDARY outcome
Timeframe: 8 weeksPopulation: Reasons for missing data include participants being unable to complete study measures due to worsening illness or death, withdrawing from the study, declining to complete the measures, or being lost to follow-up or transferring their care to another institution.
Compare the difference between study groups in the percentage of time spent immobile but awake over a consecutive three day period per actigraphy at 8 weeks. Scores range from 0% to 100%, with higher scores indicating a greater percentage of time spent immobile while awake over a consecutive three day period.
Outcome measures
| Measure |
Usual Care
n=55 Participants
Patients will receive any usual care for their dyspnea as deemed appropriate by their clinicians.
Usual Care: Patients will receive any usual care for their dyspnea as deemed appropriate by their clinicians
|
Dyspnea Intervention
n=47 Participants
Dyspnea intervention will be administered over two sessions
Patients will receive:
* Psychoeducation
* Relaxation training for reducing physiological stress
* Behavioral techniques for managing acute breathlessness
Dyspnea Intervention: Dyspnea intervention will be administered over two sessions
Patients will receive:
* Psychoeducation
* Relaxation training for reducing physiological stress
* Behavioral techniques for managing acute breathlessness
Usual Care: Patients will receive any usual care for their dyspnea as deemed appropriate by their clinicians
|
|---|---|---|
|
Activity Level (Objective Measure: Actigraphy)
|
45.80 percent time spent immobile while awake
Interval 43.06 to 48.53
|
47.42 percent time spent immobile while awake
Interval 44.46 to 50.38
|
OTHER_PRE_SPECIFIED outcome
Timeframe: 24 weeksPopulation: The analysis sample includes the total number of participants by group who completed at least one Modified Medical Research Council Dyspnea Scale outcome measure from baseline to 24 weeks.
Compare the difference between study groups in the estimated slopes of the scores on the Modified Medical Research Council Dyspnea Scale over all four assessment timepoints of 8-week intervals (i.e., baseline, 8 weeks, 16 weeks, and 24 weeks) using linear mixed effects models. The Modified Medical Research Council Dyspnea Scale scores range from 0 (minimum) to 4 (maximum), with higher scores indicating more severe dyspnea.
Outcome measures
| Measure |
Usual Care
n=121 Participants
Patients will receive any usual care for their dyspnea as deemed appropriate by their clinicians.
Usual Care: Patients will receive any usual care for their dyspnea as deemed appropriate by their clinicians
|
Dyspnea Intervention
n=126 Participants
Dyspnea intervention will be administered over two sessions
Patients will receive:
* Psychoeducation
* Relaxation training for reducing physiological stress
* Behavioral techniques for managing acute breathlessness
Dyspnea Intervention: Dyspnea intervention will be administered over two sessions
Patients will receive:
* Psychoeducation
* Relaxation training for reducing physiological stress
* Behavioral techniques for managing acute breathlessness
Usual Care: Patients will receive any usual care for their dyspnea as deemed appropriate by their clinicians
|
|---|---|---|
|
Modified Medical Research Council Dyspnea Scale (mMRCDS)
|
-0.89 mean change in scores on a scale
Interval -1.16 to -0.61
|
-0.95 mean change in scores on a scale
Interval -1.24 to -0.66
|
OTHER_PRE_SPECIFIED outcome
Timeframe: 24 weeksPopulation: The analysis sample includes the total number of participants by group who completed at least one Cancer Dyspnoea Scale outcome measure from baseline to 24 weeks.
Compare the difference between study groups in the estimated slopes of the scores on the Cancer Dyspnoea Scale over all four assessment timepoints of 8-week intervals (i.e., baseline, 8 weeks, 16 weeks, and 24 weeks) using linear mixed effects models. The Cancer Dyspnoea Scale scores range from 0 (minimum) to 48 (maximum), with higher scores indicating worse dyspnea.
Outcome measures
| Measure |
Usual Care
n=121 Participants
Patients will receive any usual care for their dyspnea as deemed appropriate by their clinicians.
Usual Care: Patients will receive any usual care for their dyspnea as deemed appropriate by their clinicians
|
Dyspnea Intervention
n=126 Participants
Dyspnea intervention will be administered over two sessions
Patients will receive:
* Psychoeducation
* Relaxation training for reducing physiological stress
* Behavioral techniques for managing acute breathlessness
Dyspnea Intervention: Dyspnea intervention will be administered over two sessions
Patients will receive:
* Psychoeducation
* Relaxation training for reducing physiological stress
* Behavioral techniques for managing acute breathlessness
Usual Care: Patients will receive any usual care for their dyspnea as deemed appropriate by their clinicians
|
|---|---|---|
|
Cancer Dyspnoea Scale (CDS)
|
-2.63 mean change in scores on a scale
Interval -4.13 to -1.13
|
-2.26 mean change in scores on a scale
Interval -3.84 to -0.67
|
OTHER_PRE_SPECIFIED outcome
Timeframe: 24 weeksPopulation: The analysis sample includes the total number of participants by group who completed at least one Functional Assessment of Cancer Therapy - Lung Scale outcome measure from baseline to 24 weeks.
Compare the difference between study groups in the estimated slopes of the scores on the Functional Assessment of Cancer Therapy - Lung Scale over all four assessment timepoints of 8-week intervals (i.e., baseline, 8 weeks, 16 weeks, and 24 weeks) using linear mixed effects models. The Functional Assessment of Cancer Therapy - Lung Scale scores range from 0 (minimum) to 136 (maximum), with higher scores indicating better quality of life.
Outcome measures
| Measure |
Usual Care
n=121 Participants
Patients will receive any usual care for their dyspnea as deemed appropriate by their clinicians.
Usual Care: Patients will receive any usual care for their dyspnea as deemed appropriate by their clinicians
|
Dyspnea Intervention
n=126 Participants
Dyspnea intervention will be administered over two sessions
Patients will receive:
* Psychoeducation
* Relaxation training for reducing physiological stress
* Behavioral techniques for managing acute breathlessness
Dyspnea Intervention: Dyspnea intervention will be administered over two sessions
Patients will receive:
* Psychoeducation
* Relaxation training for reducing physiological stress
* Behavioral techniques for managing acute breathlessness
Usual Care: Patients will receive any usual care for their dyspnea as deemed appropriate by their clinicians
|
|---|---|---|
|
Functional Assessment of Cancer Therapy - Lung (FACT-L)
|
4.86 mean change in scores on a scale
Interval 1.57 to 8.14
|
2.91 mean change in scores on a scale
Interval -0.6 to 6.41
|
OTHER_PRE_SPECIFIED outcome
Timeframe: 24 weeksPopulation: The analysis sample includes the total number of participants by group who completed at least one Hospital Anxiety and Depression Scale (HADS) - Anxiety Subscale outcome measure from baseline to 24 weeks.
Compare the difference between study groups in the estimated slopes of the scores on the Hospital Anxiety and Depression Scale - Anxiety Subscale over all four assessment timepoints of 8-week intervals (i.e., baseline, 8 weeks, 16 weeks, and 24 weeks) using linear mixed effects models. The Hospital Anxiety and Depression Scale - Anxiety Subscale scores range from 0 (minimum) to 21 (maximum), with higher scores indicating worse anxiety symptoms.
Outcome measures
| Measure |
Usual Care
n=121 Participants
Patients will receive any usual care for their dyspnea as deemed appropriate by their clinicians.
Usual Care: Patients will receive any usual care for their dyspnea as deemed appropriate by their clinicians
|
Dyspnea Intervention
n=126 Participants
Dyspnea intervention will be administered over two sessions
Patients will receive:
* Psychoeducation
* Relaxation training for reducing physiological stress
* Behavioral techniques for managing acute breathlessness
Dyspnea Intervention: Dyspnea intervention will be administered over two sessions
Patients will receive:
* Psychoeducation
* Relaxation training for reducing physiological stress
* Behavioral techniques for managing acute breathlessness
Usual Care: Patients will receive any usual care for their dyspnea as deemed appropriate by their clinicians
|
|---|---|---|
|
Hospital Anxiety and Depression Scale (HADS) - Anxiety Subscale
|
-1.00 mean change in scores on a scale
Interval -1.73 to -0.28
|
-0.28 mean change in scores on a scale
Interval -1.04 to 0.49
|
OTHER_PRE_SPECIFIED outcome
Timeframe: 24 weeksPopulation: The analysis sample includes the total number of participants by group who completed at least one Hospital Anxiety and Depression Scale - Depression Subscale outcome measure from baseline to 24 weeks.
Compare the difference between study groups in the estimated slopes of the scores on the Hospital Anxiety and Depression Scale - Depression Subscale over all four assessment timepoints of 8-week intervals (i.e., baseline, 8 weeks, 16 weeks, and 24 weeks) using linear mixed effects models. The Hospital Anxiety and Depression Scale - Depression Subscale scores range from 0 (minimum) to 21 (maximum), with higher scores indicating worse depression symptoms.
Outcome measures
| Measure |
Usual Care
n=121 Participants
Patients will receive any usual care for their dyspnea as deemed appropriate by their clinicians.
Usual Care: Patients will receive any usual care for their dyspnea as deemed appropriate by their clinicians
|
Dyspnea Intervention
n=126 Participants
Dyspnea intervention will be administered over two sessions
Patients will receive:
* Psychoeducation
* Relaxation training for reducing physiological stress
* Behavioral techniques for managing acute breathlessness
Dyspnea Intervention: Dyspnea intervention will be administered over two sessions
Patients will receive:
* Psychoeducation
* Relaxation training for reducing physiological stress
* Behavioral techniques for managing acute breathlessness
Usual Care: Patients will receive any usual care for their dyspnea as deemed appropriate by their clinicians
|
|---|---|---|
|
Hospital Anxiety and Depression Scale (HADS) - Depression Subscale
|
-0.18 mean change in scores on a scale
Interval -0.89 to 0.53
|
-0.10 mean change in scores on a scale
Interval -0.85 to 0.66
|
OTHER_PRE_SPECIFIED outcome
Timeframe: 24 weeksPopulation: The analysis sample includes the total number of participants by group who completed at least one Godin-Shephard Leisure Time Physical Activity Questionnaire outcome measure from baseline to 24 weeks.
Compare the difference between study groups in the estimated slopes of the scores on the Godin-Shephard Leisure Time Physical Activity Questionnaire over all four assessment timepoints of 8-week intervals (i.e., baseline, 8 weeks, 16 weeks, and 24 weeks) using linear mixed effects models. The Godin-Shephard Leisure Time Physical Activity Questionnaire is a 4-item measure that assesses the frequency and extent of physical activity during free time over the course of one week, with scores ranging from 0 (minimum; insufficiently active) to 24 or greater (maximum; active), with higher scores indicating greater physical activity.
Outcome measures
| Measure |
Usual Care
n=119 Participants
Patients will receive any usual care for their dyspnea as deemed appropriate by their clinicians.
Usual Care: Patients will receive any usual care for their dyspnea as deemed appropriate by their clinicians
|
Dyspnea Intervention
n=121 Participants
Dyspnea intervention will be administered over two sessions
Patients will receive:
* Psychoeducation
* Relaxation training for reducing physiological stress
* Behavioral techniques for managing acute breathlessness
Dyspnea Intervention: Dyspnea intervention will be administered over two sessions
Patients will receive:
* Psychoeducation
* Relaxation training for reducing physiological stress
* Behavioral techniques for managing acute breathlessness
Usual Care: Patients will receive any usual care for their dyspnea as deemed appropriate by their clinicians
|
|---|---|---|
|
Activity Level (Self-report: Godin-Shephard Leisure Time Physical Activity Questionnaire)
|
0.54 mean change in scores on a scale
Interval -5.3 to 6.38
|
1.28 mean change in scores on a scale
Interval -5.09 to 7.65
|
OTHER_PRE_SPECIFIED outcome
Timeframe: 24 weeksExamine the degree to which intervention effects on patient reported outcomes are mediated by improved mastery in managing breathlessness (as measured by the Chronic Respiratory Disease Questionnaire)
Outcome measures
Outcome data not reported
OTHER_PRE_SPECIFIED outcome
Timeframe: 24 weeksExamine whether differences in reported dyspnea are moderated by patient demographic and clinical factors
Outcome measures
Outcome data not reported
OTHER_PRE_SPECIFIED outcome
Timeframe: 24 weeksExamine differences between study groups in rates of emergency department and hospitalizations
Outcome measures
Outcome data not reported
Adverse Events
Usual Care
Dyspnea Intervention
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place